Review. Clomipramine in acute and chronic pain syndromes

References

• Bourel M, Sabouraud O. Tofranil et douleur. Semther 1962; 38: 643–5
   Google Scholar
• Lapeyre L, Commandre F, Baralis G, Taramasco H, Guillemin R. Le syndrome sympathique neuro-osteo-trophique du zone. Rhumatologie 1963; 15: 227–37
   PubMedGoogle Scholar
• Araujo CA. La sedación del dolor del cáncer de pulmón. Dia méd 1965; 37
   Google Scholar
• Reisner H. Psychopharmaka und schmertzbe-kämpfung. Muskel und Psyche. Symp Wien1963. Karger., Basel. New York 1964; 116–8
   Google Scholar
• Burrows G D, Elton D, Stanley GV. Handbook of chronic pain management. Elsevier Amsterdam New York Oxford 1987; 1–437
   Google Scholar
• Sternbach R. A., Janowsky D. S., Huey L. Y., Segal D. S. Effects of altering brain serotonin activity on human chronic pain. Advances in pain research and therapy, JJ. Bonica, DG. Albe-Fessard. Raven Press, New York 1976; Vol 1: 601–606.
   Google Scholar
• von Knorring L. The experience of pain in patients with depressive disorders. A clinical and experimental study. Medical Thesis, Umeå University. 1975, New series No. 2
   Google Scholar
• Lindsay PhG, Wycoff M. The depression-pain syndrome and its response to antidepressants. Psychosomatics 1981; 22: 571–7
   PubMed Web of Science ®Google Scholar
• von Knorring L. Affect and pain: neurochemical mediators and therapeutic approaches. Pain Research and Clinical management, R. Dubner, GF. Gebhart, MR. Bond. Elsevier., Amsterdam. New York, Oxford, Volume 3.: 276–285, Proceedings of the Vth World Congress on Pain
   Google Scholar
• Lascelles RG. Atypical facial pain and depression. Br J Psychiatry 1966; 112(488)651–9
   PubMedGoogle Scholar
• Merskey H, Spear FG. Pain. Psychological and psychiatric aspects. Bailliere. Tindall and Cassell., London 1967
   Google Scholar
• Messing R B, Lytle LD. Serotonin-containing neurons: their possible role in pain and analgesia. Pain 1977; 4: 1–21
   PubMed Web of Science ®Google Scholar
• Basbaum A I, Fields HL. Endogenous pain control mechanism: Review and hypothesis. Ann Neurol 1978; 4: 451–62
   PubMed Web of Science ®Google Scholar
• Johansson F, von Knorring L. A double blind controlled study of a serotonin uptake inhibitor (zimelidine) versus placebo in chronic pain patients. Pain 1979; 7: 69–78
   PubMed Web of Science ®Google Scholar
• Messing R. B., Phebus L., Fischer I. Analgesic effect of fluoxethine HCL (Lilly 110140) a specific uptake inhibitor for serotoninergic neurons. Psy-chopharmacol Commun 1975; 1: 511–21
   PubMedGoogle Scholar
• Taub A. Relief of post-heretic neuralgia with psychotropic drugs. J Neurosurg 1973; 39: 235–9
   PubMed Web of Science ®Google Scholar
• Messing R. B., Wilcox G. L. Non-opioid neurotransmitters in pain perception and analgesia. Handbook of chronic pain management, G. D. D. Burrows, G. V. Stanley Elton. Elsevier, Amsterdam. New York. Oxford 1987; 19–32
   Google Scholar
• Hwang A S, Wilcox GL. Analgesic properties of intrathecally administered heterocyclic antidepressants. Pain 1987; 28: 343–55
   PubMed Web of Science ®Google Scholar
• Maitre L, Bauman P A, Jaekel J, Waldmeier PC. 5-HT uptake inhibitors: Psychopharmacological and neurochemical criteria of selectivity. Advanc Biochem Psychopharmacol (USA) 1982; 34: 229–46
   PubMedGoogle Scholar
• Eberhard G, von Knorring L, Nilsson HL, et al. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes. Ncuropsychobiology 1988; 19: 25–34
   PubMed Web of Science ®Google Scholar
• Fogelholm R, Murros K. Maprotiline in chronic tension headache: a double blind cross-over study. Headache 1985; 25(5)273–5
   PubMedGoogle Scholar
• Klein W. Behandlung chronischer Ruecken-schmerzen und schmerzen nach Bandscheiben-operationen. Infusionstherapie mit maprotiline. Krankenhausarzt 1987; 60(6)451–3
   Google Scholar
• Typical and atypical antidepressants. Molecular mechanisms. Advances in biochemical psychopharmacology, E Costa, G Racagni. Raven Press, New York 1982; 31: 1–391
   Google Scholar
• CIBA Foundation Symposium. Antidepressants and receptor function. John Wiley & Sons, Chichester New York Brisbrane Toronto Singapore 1986; 123: 1–295
   Google Scholar
• Akil H, Liebeskind JC. Monoaminergic mechanisms of stimulation-produced analgesia. Brain Res 1975; 94(2)279–96
   PubMedGoogle Scholar
• Hayes R L, Newlon P G, Rosecrans J A, Mayer DJ. Reduction of stimulation-produced analgesia by lysergic acid deithylamide, a depressor of serotonergic neural activity. Brain Res 1977; 122(2)367–72
   PubMedGoogle Scholar
• Sicuteri F. Pain syndrome in man following treatment with p-chlorophenylalanine. Pharmacol Res Comm 1971; 3: 4, 401–7
   Google Scholar
• Sacerdote P, Brini A, Mantegazza P, Panerai A. E. A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressants drugs. Pharma Biochem Behaviour 1987; 26: 153–8
   PubMedGoogle Scholar
• Rosland J H, Hunskaar S, Hole K. Effects of clomipramine on morphine analgesia in mice. Pain 1987; 4: S44, Suppl. Abs
   Google Scholar
• Tulunay F. C., Yano I, Takemori A. E. The effect of biogenic amine modifiers on morphine analgesia and its antagonism by naloxone. Eur J Pharmacol 1976; 35
   PubMedGoogle Scholar
• Tiengo M, Pagnoni B, Calmi A, et al. Clomipramine compared with pentazocine as a unique treatment in postoperative pain. Int J Clin Pharm Res 1987; VII(2)141–3
   Google Scholar
• Nobili R, Corli O, Roma G, Morandi C, Bracco S, Panerai AE. Clomipramine and baclofen in voluntary abortion analgesia: A placebo controlled study. PAIN Aug, 1987; S90, Suppl Vth World Congr. Pain, IASP. Hamburg. FRG. 2–7 Abs.
   Google Scholar
• Fatela L V, Madrid J L, Alcorta J, Guillén Gozalo F. A. IV infusion of clorimipramine in deafferentation chronic pain. PAIN 1987; S394, Vth World Congr Pain. IASP, Hamburg. FRG. 2–7 Aug Suppl Abs.
   Google Scholar
• Montastruc J L, Tran MA, Charlet JP, et al. Étude des propriétés analgésiques et des concentrations plasmatiques de clomipramine dans les douleurs chroniques. Rev Neurol (Paris) 1983; 139(10)583–7
   PubMedGoogle Scholar
• Montastruc J L, Tran M A, Blanc M, et al. Measurements of plasma levels of clomipramine in the treatment of chronic pain. Clin Neuropharm 1985; 8 (1): 78–82
   Google Scholar
• Kuromaru S. Therapy of phantom limb (translated from Japanese). Nippon Seikeigeka Gakkai Zasshi 1968; 42(8)607–8
   Google Scholar
• Poiret-Riblet E. Action de la clomipramine sur certain douleurs en neurologie. These Clermont 1978; 1–71
   Google Scholar
• Castaigne D, Laplane R, Morales R. Traitement par la clomipramine des douleurs des neuropathies peripheriques. Nouv med 1979; 8(11)843–5
   PubMedGoogle Scholar
• Langohr H D, Stöhr M, Petruch F. An open and double blind cross-over study on the efficacy of clomipramine (ANAFRANIL) in patients with painful mono- and polyneuropathies. Eur Neurol 1982; 21: 309–17
   PubMed Web of Science ®Google Scholar
• von Langohr HD, Gläser N, Mayer K. Ergebnisse einer Behandlung von schmerzhaften mono- und polyneuropathien mit psychotropen medikamen-ten und transkutaner elektrischer nervenstimulation. Schmertz 1983; 1: 12–6
   Google Scholar
• Pellat J, Larribau E. Utilisation de la clomipramine dans le traitement de certaines algies en pratique neurologique. Rev méd alpes franc 1976; 5(7)49–52
   Google Scholar
• Bourgoin S, Cesselin F, Gozlan H, et al. Chronic chlorimipramine does not reverse the reduction of cerebrospinal fluid met-enkephalin-like immuno-reactivity in chronic pain patients. Clin Neuropharm 1987; 10(5)434–42
   PubMedGoogle Scholar
• Panerai A E, Tiengo M, Movilia P G, Bianchi M, Monza GC. A controlled clinical trial on the effectiveness of antidepressants in central pain. Vth World Congr Pain, IASP, Hamburg, FRG Aug, 1987, Abs
   Google Scholar
• Carasso R L, Yehuda S, Streifler M. Clomipramine and amitriptyline in the treatment of severe pain. Intern J Neuroscience 1979; 9: 191–4
   PubMed Web of Science ®Google Scholar
• Tsuji M, Iida H. Treatment of headache with antidepressants. Folia Psychiat Neurol Jap 1984; 38(2)143–9
   PubMedGoogle Scholar
• Duclos H. Étude de l'action de l'imipramine et de la clomipramine sur la maladie migraineuse. Gaz méd Fr 1978; 85(9)951–6
   Google Scholar
• Noone JF. Psychotropic drugs and migraine. J Int Med Res 1977; 5: 66–71, Suppl. 1
   PubMedGoogle Scholar
• Langemark M., Poulsen D. Mianserin and clomipramine in the treatment of chronic tension headache. A double-blind, placebo controlled study. The migraine trust 6th International Migraine symp 14th-16th October 1986; 73–4, Abstr.
   Google Scholar
• Bresson P. Essais cliniques de medications nouvel-les. Contribution a l'étude de Paction antalgigue d'un antidépresseur majeur. Clermont-méd 1971; 19: 89–91
   Google Scholar
• Blintzowsky P. L'Anafranil en milieu hospitalier rhumatologique. Actua 1978; 10(218)49–51
   Google Scholar
• Regalado RG. Clomipramine (ANAFRANIL) and musculoskeletal pain in general practice: A pilot, open, non-comparative study of long-standing rheumatic pain. J Int Med Res 1977; 5: 72–7, Suppl. 1
   PubMedGoogle Scholar
• Miyar V M, Costa C E, Torrens EF. Tratamiento farmacológico de los llamados “reumatismo psicógenos”. Rev Depart Psquit Fac Med Barcelona 1978; 5(2)92–116
   Google Scholar
• Ganvier P, Beaumont G, Seidrup J. A comparative trial of clomipramine and placebo as adjunctive therapy in arthralgia. J Int Med Res 1980; 8: 60–6, Suppl. 3
   PubMedGoogle Scholar
• Serin D. Contribution á l'étude de Taction antalgigue d'un antidépresseur en carcinologie générale. Lyon med 1974; 232(17)483–7
   Google Scholar
• Gebhardt K-H, Belter J, Nischk R. Behandlung des karzinomschmerzes mit chlorimipramin (ANAFRANIL). Med 1969; 64(16)751–6
   Google Scholar
• Leroy G. Étude de la clomipramine en association avec la lévomépromazine dans un but antalgigue chez les malades O.R.L. porteurs d'une néoplasie. Gaz med Fr 1982; 89(37)4566–71
   Google Scholar
• Mascles JC. Étude de l'Anafranil dans les douleurs des cancéreux. A propos de 35 observations. Progr 1976; 104(7)163–4
   Google Scholar
• Bernard P HA, Scheuer H. Action de la clomipramine (ANAFRANIL) sur la douleur des cancers en pathologie cervico-faciale. J France Oto Rhino Laryng 1972; 21(8)723–8
   Google Scholar
• Dofing J-L. Emploi de l'ANAFRANIL en carcinologie gastro-enterologigue dans le but de retarder l'emploi des antalgiques majeurs. Rev franc Gastro Ent 1973; 92: 81–4
   Google Scholar
• Beaumont G, Seidrup J. Comparative trial of clomipramine and placebo in the treatment of terminal pain. J Int Res 1980; 8: 67–9, Suppl. 3
   Google Scholar
• Kocher R, Muller O. Analgetische Wirkungen von Psychopharmaka eine Literaturübersicht, R. Kocher, 1987; 76–90, Workshop vom 21–23 1987, CIBA-GEIGY
   Google Scholar
• Drevet M. Eléments psychosomatiques dans un cas d'algodystrophie sévère du membre supérieur: signification d'un accès mèlancolique intercurrent. J Méd Lyon 1973; 1251(20)929–40
   Google Scholar
• Tilscher H, Vole D, Friedrich M. Klinik und Befunde von Schmerzsyndromen der Bewegung-sapparates bei patienten mit gestörter Psyche. Z Orthop 1984; 122 (4): 393–7
   Google Scholar
• Richou H, Moral J, Naphon JP. Intérét et tolérance de l'ANAFRANIL 10 chez 89 malades traités en ambulatoire pour des manifestations psycho-fonctionelles avec tendances depressives. Actualités psychiat 1978; 8 (4): 113–5
   Google Scholar
• du Giraud, Poyet D. Les etats depressifs en medecine interne. Thesis, Marseilles Jan 31, 1973
   Google Scholar
• Agricola R, Gallo V, Mazzarino M, Urani R. Studio clinico comparativo in doppio cieco tra la ma-protilina e la clomipramina nelle depressioni ma-scherate. Gaz Med It 1982; 141: 451–9
   Google Scholar
• Williams J.B.W, Spitzer R. L. Idiopathic pain disorder: a critique of pain-prone disorder and a proposal for a revision of the DSM-III category psychogenic pain disorder. J Nerv Ment Dis 1982; 170: 415–9
   PubMed Web of Science ®Google Scholar
• Jørgensen B, Nørrelund N, Bech P, Jakobsen K. Smerter og depressive symptomer i almen praksis. En kontrollert undersøgelse af ANAFRANIL (klomipramin) versus placebo. Ugeskr 1984; 146(38)2868–71
   PubMedGoogle Scholar
• Loldrup D, Langemark M, Hansen H J, Olesen J, Bech P. Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. Psychopharmacoiogy 1989, in press
   PubMedGoogle Scholar
• Bech P, Jörgensen B, Nörrelund N, et al. Pain as presentation symptoms of depression in liason psychiatry evidenced by outcome to clomipramine. Two placebo controlled trials. Nord Psykiatr Tidsskr 1989; 43: 89–94, Suppl 20
   Google Scholar
• France RD. The future for antidepressants: Treatment of pain. Psychopathology 1987; 20: 99–113, suppl. 1
   PubMedGoogle Scholar
• Kocher R. Die Behandlung chronischer Kreuzsch-merzen mit Psychopharmaka. Muench med Wschr 1977; 119(39)1241–4
   Google Scholar
• Kocher R, Meissner C. Treatment of chronic painful conditions with clomipramine (ANAFRANIL). CIBA-GEIGY 1987; 1–38
   Google Scholar
• Eberhard G, von Knorring L, Nilsson H. L., Sundequist U. Predictors for the outcome of treatment with antidepressants in patients with idiopathic pain syndromes. Nord Psykiatr Tidsskr 1989; 43: 115–121, Suppl. 20
   Google Scholar
• American Psychiatric Associatoin (APA). Diagnostic and statistical manual of mental disorders 3rd ed. American Psychiatric Association, Washington 1987; 1–567
   Google Scholar